Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PsiOxus Pursues CAR-T Mirror Image Strategy Into Clinic

Executive Summary

Bankrolled by upfront and milestone payments associated with deals it has with Bristol-Myers Squibb, Oxford, UK-based gene therapy company PsiOxus Therapeutics is targeting two INDs in 2018 and two in 2019. Company CEO John Beadle outlined his near term plans for the unpartnered programs to Scrip during the 2018 Biotech Showcase.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts